XML 14 R4.htm IDEA: XBRL DOCUMENT v3.23.1
CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($)
12 Months Ended
Dec. 31, 2022
Dec. 31, 2021
Revenues:    
Product sales $ 3,861,205 $ 805,969
Product sales - related parties and subsidiaries 60,626 139,114
Manufacturing service 43,409 242,190
Consulting services, related parties 2,100 0
Total revenues 3,967,340 1,187,273
Cost of sales, related parties 3,796 0
Cost of sales 3,724,498 850,901
Total cost of sales 3,728,294 850,901
Gross profit from operations 239,046 336,372
Operating expenses:    
General and administrative 2,639,285 981,676
General and administrative, related parties 606,842 469,259
Sales and marketing 858,296 542,680
Impairment loss on equipment and trademarks 1,721,663 0
Sales and marketing, related 26,660 0
Expensing of related party advances and loans 1,470,522 0
Research and development 0 2,090
Total operating expenses 7,323,268 1,995,705
Operating loss (7,084,222) (1,659,333)
Other income (expense):    
Interest expense, net (47,265) (209,676)
Other expense, net (3,470) (1,666)
Income before income taxes (7,134,957) (1,870,675)
Provision for income taxes 0 0
Net loss (7,134,957) (1,870,675)
Net profit/(loss) attributable to non-controlling interests (131,123) (14,250)
Net profit/(loss) attributable to Hempacco Co., Inc. (7,003,834) (1,856,425)
Dividends issued to preferred stockholders 0 757,479
Net loss attributable to common shareholders $ (7,003,834) $ (2,613,904)
Basic and dilutive earnings per share: $ (0.33) $ (0.18)
Shares used in calculation of earnings per share: 21,393,862 14,641,224